Back
Verrica Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
29
VRCA
Verrica Pharmaceuticals
Last Price:
$0.70
Seasonality Move:
20.88%
Sell
49
NBY
NovaBay Pharmaceuticals
Last Price:
$0.61
Seasonality Move:
15.02%
Sell
29
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.70. The Score for VRCA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.62. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.70The current trend is relatively stagnant and VRCA is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.62The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 36.58 | Sell |
Chaikin Money Flow: | 42937 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.64 - 1.08) | Sell |
Bollinger Bands (100): | (0.7 - 2.36) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 56.07 | Buy |
Chaikin Money Flow: | -8007 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.54 - 0.6) | Buy |
Bollinger Bands (100): | (0.51 - 0.69) | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.69 | Buy |
20-day SMA: | 0.76 | Sell |
50-day SMA: | 0.99 | Sell |
200-day SMA: | 4.42 | Sell |
8-day EMA: | 0.7 | Sell |
20-day EMA: | 0.78 | Sell |
50-day EMA: | 1.09 | Sell |
200-day EMA: | 3.24 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.58 | Buy |
20-day SMA: | 0.56 | Buy |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.71 | Sell |
8-day EMA: | 0.59 | Buy |
20-day EMA: | 0.58 | Buy |
50-day EMA: | 0.63 | Sell |
200-day EMA: | 4.39 | Sell |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.26 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.
Verrica Pharmaceuticals Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |